drugset / Trial / NCT02772562
Adjuvant PROSTVAC-V/F in Subjects at High Risk for Relapse After Radical Prostatectomy
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to see how well PROSTVAC -V/F works in stopping prostate cancer from coming back or relapsing. This study will also look at the safety of PROSTVAC-V/F.
Timeline
- Start
- 2016-07-18
- Primary completion
- 2024-04-29
- Completion
- 2024-04-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PROSTVAC-F | Vaccine | 1e+09 iu | — |
| Subject | PROSTVAC-V | Vaccine | 2e+08 iu | — |